Key result
AI-enhanced CVRM eCoach undergoes evaluation to reduce 10-year ASCVD risk.
Why the study?
Identifying apparently healthy individuals at risk for cardiovascular diseases can raise awareness and guide tailored prevention, prompting evaluation of an AI-enhanced personalized eCoach approach.
Does a personalized CVRM eCoach approach reduce the 10-year risk of atherosclerotic cardiovascular disease in apparently healthy individuals eligible for CVRM?
Does a personalized CVRM eCoach approach reduce the 10-year risk of atherosclerotic cardiovascular disease in apparently healthy individuals eligible for CVRM?
This protocol outlines a pretest-posttest study to evaluate whether an AI-driven personalized eCoach solution can reduce the 10-year risk of atherosclerotic cardiovascular disease in primary care.
Answers are grounded in this paper and cite their sources.
Protocol evaluates AI-personalized eCoach for primary CVRM; leaves open reduction in 10-year ASCVD risk.
BACKGROUND: Atherosclerotic cardiovascular disease poses a heavy burden on the population's health and health care costs. Identifying apparently healthy individuals at risk of developing cardiovascular diseases using clinical prediction models raises awareness, facilitates shared decision-making, and supports tailored management of disease prevention. In the CARRIER project, a personalized cardiovascular risk management (CVRM) eCoach approach is cocreated, in which identified individuals receive education, guidance, and monitoring to prevent atherosclerotic cardiovascular disease through existing interventions. In this approach, an artificial intelligence-driven clinical prediction model calculates the 10-year risk for atherosclerotic cardiovascular disease, which supports informed decision-making. OBJECTIVE: This study aims to assess the effectiveness of our CVRM eCoach approach through a 10-year risk calculation of atherosclerotic cardiovascular disease, including risk factors contributing to this risk. METHODS: This pretest-posttest interventional study provides the CVRM eCoach approach for 6 months to 100 apparently healthy individuals eligible for CVRM. The CVRM eCoach approach is a multicomponent eHealth solution, including a clinical prediction under intervention model that not only calculates the 10-year risk of cardiovascular disease through conventional risk factors (smoking, blood pressure, and lipid profile) and individual characteristics (age, gender, socioeconomic status, physical activity, and diet) but also calculates how the risk changes after hypothetical lifestyle or medical interventions. The CVRM eCoach approach includes features that encourage behavior change. Most of these features include goal setting, decision cards to help decide on an intervention, intervention monitoring, remote communication, and education, all accessible from one dashboard. A practice nurse or physician consults the individuals after risk calculation with the clinical prediction model and uses behavior change features, such as the decision cards, to support shared decision-making. Data are primarily collected via the eCoach, after which the 10-year risk for atherosclerotic cardiovascular disease and its components are analyzed using paired-sample analyses. RESULTS: Recruitment began in March 2024 and will continue until 100 participants have been recruited, which is expected in 2025. CONCLUSIONS: We anticipate that our CVRM eCoach approach will be valuable in the primary prevention setting. During the crucial initial first months of habit formation, factors such as education, regular check-ups via the eCoach, and clear risk communication could support individuals in sustaining their medical or lifestyle interventions. We hypothesize that there will be a slight to moderate reduction in the 10-year risk of atherosclerotic cardiovascular disease, which over time will lead to significant health improvements on a larger scale. TRIAL REGISTRATION: CCMO NL84584.096.23; https://onderzoekmetmensen.nl/nl/trial/56578.
No takes yet. Share an insight, caveat, or question.
Mierlo et al. (2025) studied Atherosclerotic cardiovascular disease risk (n=100). CVRM eCoach approach vs. Baseline was evaluated on Change in calculated 10-year ASCVD risk. The personalized CVRM eCoach approach, enhanced by an AI-driven clinical prediction model, will be evaluated for its effectiveness in reducing the estimated 10-year ASCVD risk over 6 months.
Synapse has enriched 10 related papers. Consider them for comparative context: